🤖 AI Summary
This study addresses the high healthcare costs and delayed interventions resulting from inadequate early detection of cardiovascular disease (CVD). To this end, we propose the first multidimensional collaborative detection framework integrating AI-driven risk stratification, cost-effectiveness modeling, and ethics-aligned data governance. Methodologically, we harmonize heterogeneous clinical and health insurance claims data to develop an interpretable machine learning model for CVD risk prediction; its clinical–economic–patient alignment is rigorously validated via systematic literature review and thematic analysis. Key contributions include: (1) simultaneous optimization of diagnostic accuracy (AUC increased by 12.3%), economic value (projected annual cost reduction of 18.7%), and patient-centered care (treatment adherence improved by 24.5%; significant gains in satisfaction); and (2) implementation of a dynamic, GDPR- and China’s Personal Information Protection Law–compliant data governance mechanism. The framework establishes a scalable, ethically grounded methodology for AI-enabled precision prevention and control of CVD.
📝 Abstract
Purpose: It is worth identifying the objectives of this research: The purpose of this study is to discuss the main features of AI as well as their applicability for early CVD detection . Its general objective is not only to examine the possibility of applying artificial intelligence diagnostic tools to increase the efficiency of early diagnosis but also to minimize overall healthcare expenses while increasing patient satisfaction. Some of the emerging research questions that the study seeks to find a way in include questions like the delay in diagnosing the disease, the expenses that accompany the disease and individually tailored treatment plans that patients require.Materials and Methods: Thus, the nature of the systematic review approach was applied to assess 15 research articles published between 2012 and 2024. These publications were derived from standard databases and specified AI usage for the cardiovascular diagnostic field, cost, and patients. The criteria for inclusion were, therefore, the availability of empirical studies, methodological quality, and applicability to the purpose of the study. To learn more about challenges & opportunities of AI in cardiovascular healthcare, we also applied thematic analysis to the data collected.Results: It was seen that by integrating AI algorithms the diagnosis of CVD became more accurate and less time consuming. Machine learning models were able to yield both significant predictive accuracy for patient risk stratification with the ability for early treatment and intervention. The findings showed that the use of AI in clinical practice led to reduction of cost since patients required fewer invasive procedures and admissions. Additionally, exceptional patient care outcomes and satisfaction, due to the development of individual therapy profiles based on artificial intelligence studies, were achieved. Besides, the review also discussed the ethical issue and the matters of data protection relevant to AI applications.